| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3303d8dc7ea7ec352cc3a4761327b302 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16032 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2011-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6b98ede88e4e1079ed513f2a52ab83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0d25e593862adcec0a87adf0a1ef9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce0012cca7f3e9152560d34bb791dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3fbf8d72bf327aa5513267e4b21d013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9873ff42439238cef37f4a83e75f54e0 |
| publicationDate |
2013-01-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2547353-A2 |
| titleOfInvention |
Cancer treatment with recombinant vector |
| abstract |
This disclosure provides modified cytosine deaminases (CDs). The disclosure further relates to cells and vector expressing or comprising such modified CDs and methods of using such modified CDs in the treatment of disease and disorders. It further provides use of such modified CDs with a thymosin-alpha-1 polypeptide in the treatment of disease and disorders. |
| priorityDate |
2010-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |